Novo has made similar claims about the challenges of Victoza manufacturing in the past. Back in 2017, the drugmaker filed a separate citizen petition arguing that the production process for the ...

On Dec. 23, the FDA approved Hikma Pharmaceuticals' liraglutide injection, a generic version of Novo Nordisk's Victoza. The FDA first approved Victoza in 2010 for Type 2 diabetes, later expanding ...

Victoza is a brand-name subcutaneous injection that doctors prescribe to manage blood sugar and reduce the risk of certain cardiovascular events in people with type 2 diabetes. It contains the ...

Novo Nordisk has settled a US patent case with Teva, which prevents the Israel-based generics firm marketing a cheaper version of its key type 2 diabetes drug Victoza until 2023.